1 |
matrix metalloproteinase
(11512 times)
|
Neoplasms (1610 times)
|
TIMP (1104 times) IL (836 times) ECM (623 times)
|
1990 The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family.
|
2 |
mitochondrial membrane potential
(3023 times)
|
Biochemistry (377 times)
|
ROS (1456 times) NAC (162 times) LDH (160 times)
|
1992 Involvement of intracellular Ca2+ and K+ in dissipation of the mitochondrial membrane potential and cell death induced by extracellular ATP in hepatocytes.
|
3 |
mucous membrane pemphigoid
(212 times)
|
Dermatology (75 times)
|
BP (26 times) BMZ (20 times) PV (19 times)
|
1985 Localization of basement membrane components in mucous membrane pemphigoid.
|
4 |
monomethyl phthalate
(94 times)
|
Environmental Health (65 times)
|
MEHP (50 times) MEP (48 times) MBP (37 times)
|
1991 Mutagenicity and metabolism of dimethyl phthalate and its binding to epidermal and hepatic macromolecules.
|
5 |
Medical Monitoring Project
(48 times)
|
Acquired Immunodeficiency Syndrome (20 times)
|
HIV (15 times) ART (14 times) CI (6 times)
|
2007 Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: the rationale for developing a population-based approach.
|
6 |
matched molecular pair
(26 times)
|
Chemistry (14 times)
|
SAR (5 times) QSAR (3 times) MMPA (2 times)
|
2010 Computationally efficient algorithm to identify matched molecular pairs (MMPs) in large data sets.
|
7 |
methadone maintenance program
(20 times)
|
Medicine (6 times)
|
AMP (2 times) DFP (2 times) HIV (2 times)
|
1989 [Prevalence of buprenorphine use by heroin addicts undergoing treatment].
|
8 |
membrane potential
(18 times)
|
Neurology (4 times)
|
ROS (6 times) ER (3 times) mtROS (2 times)
|
1996 Functional heterogeneity of an isolated mitochondrial population revealed by cytofluorometric analysis at the single organelle level.
|
9 |
microsatellite mutator phenotype
(18 times)
|
Neoplasms (8 times)
|
MMR (3 times) AP-PCR (2 times) MSI (2 times)
|
1995 The microsatellite mutator phenotype of colon cancer cells is often recessive.
|
10 |
major membrane protein
(14 times)
|
Allergy and Immunology (5 times)
|
BCG (5 times) DC (4 times) HSP (4 times)
|
1990 The major native proteins of the leprosy bacillus.
|
11 |
magnetic microparticle
(13 times)
|
Biotechnology (3 times)
|
BCA (5 times) BTV (2 times) GNP (2 times)
|
2006 Preparation, characterization and surface study of poly-epsilon caprolactone magnetic microparticles.
|
12 |
matrix-degrading metalloproteinase
(13 times)
|
Vascular Diseases (4 times)
|
TIMP (2 times) UVB (2 times) VSMC (2 times)
|
1997 Two transcription factors, E1AF and N-myc, correlate with the invasiveness of neuroblastoma cell lines.
|
13 |
masticatory muscle pain
(11 times)
|
Dentistry (9 times)
|
MPI (2 times) TMD (2 times) EPT (1 time)
|
1998 Psychological and physiological parameters of masticatory muscle pain.
|
14 |
Mini-Mental Parkinson
(11 times)
|
Neurology (4 times)
|
MMSE (7 times) PD (4 times) ACE-R (2 times)
|
2010 Metric properties of the mini-mental Parkinson and SCOPA-COG scales for rating cognitive deterioration in Parkinson's disease.
|
15 |
masticatory myofascial pain
(10 times)
|
Dentistry (6 times)
|
VAS (4 times) PPT (2 times) RDC/TMD (2 times)
|
2002 Masticatory myofascial pain: an explanatory model integrating clinical, epidemiological and basic science research.
|
16 |
methadone maintenance patients
(9 times)
|
Substance-Related Disorders (8 times)
|
ADHD (1 time) AHA (1 time) CalCAP (1 time)
|
1995 Contingent reinforcement for reduced carbon monoxide levels in methadone maintenance patients.
|
17 |
mean melting point
(8 times)
|
Endocrinology (3 times)
|
FA (3 times) PL (3 times) DBI (2 times)
|
1991 Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation.
|
18 |
mitochondrial myopathy
(8 times)
|
Cardiology (4 times)
|
BMD (4 times) CI (3 times) MD (3 times)
|
1996 [Heart muscle involvement in myopathies].
|
19 |
minimum miscibility pressure
(7 times)
|
Chemistry Techniques, Analytical (2 times)
|
FCM (1 time) HPHT (1 time) MMC (1 time)
|
2005 Determination of gas-oil miscibility conditions by interfacial tension measurements.
|
20 |
modified Mallampati grade
(7 times)
|
Otolaryngology (7 times)
|
BMI (6 times) AHI (5 times) OSA (3 times)
|
1999 Clinical predictors of obstructive sleep apnea.
|
21 |
multichannel matching pursuit
(7 times)
|
Neurology (4 times)
|
EEG (2 times) ICA (2 times) SVM (2 times)
|
2009 Inverse modeling on decomposed electroencephalographic data: a way forward?
|
22 |
maximal mean power
(6 times)
|
Sports Medicine (4 times)
|
AT (1 time) BCM (1 time) CP (1 time)
|
2005 Power output during women's World Cup road cycle racing.
|
23 |
medication management program
(6 times)
|
Pharmacy (2 times)
|
CI (1 time) ED (1 time) OR (1 time)
|
2015 Pharmacist-led medication management program within a patient-centered medical home.
|
24 |
medium molecular peptides
(6 times)
|
Urology (2 times)
|
EI (2 times) AOMP (1 time) ATFE (1 time)
|
1991 [Blood levels of medium molecular weight peptides and lipid peroxidation activity in the differential diagnosis of diffuse toxic goiter].
|
25 |
membrane metalloproteases
(6 times)
|
Physiology (2 times)
|
AD (1 time) Ang (1 time) Ang II (1 time)
|
2003 Regulation of trophoblastic gelatinases by proto-oncogenes.
|
26 |
metabolites, monomethyl phthalate
(6 times)
|
Environmental Health (3 times)
|
MEP (5 times) MEHP (4 times) mBP (3 times)
|
2003 Improved quantitative detection of 11 urinary phthalate metabolites in humans using liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry.
|
27 |
Multiple Multipole Program
(6 times)
|
Biophysics (3 times)
|
LSPR (2 times) AFM (1 time) FEM (1 time)
|
2005 Induced current density in the foetus of pregnant workers in high magnetic field environments.
|
28 |
2-methoxy-4-methylphenol
(5 times)
|
Neoplasms (3 times)
|
BPO (2 times) HSG (2 times) AC (1 time)
|
2004 Kinetic radical scavenging activity and cytotoxicity of 2-methoxy- and 2-t-butyl-substituted phenols and their dimers.
|
29 |
Marine Mammal Program
(5 times)
|
Veterinary Medicine (4 times)
|
EBC (1 time) GGT (1 time)
|
2008 Trace and non-trace elements in blood cells of bottlenose dolphins (Tursiops truncatus): variations with values from liver function indicators.
|
30 |
membrane mitochondrial potential
(5 times)
|
Pediatrics (1 time)
|
ROS (2 times) A. muricata (1 time) CTAs (1 time)
|
2009 Candida albicans experimental infection: effects on human sperm motility, mitochondrial membrane potential and apoptosis.
|
31 |
methylmannose polysaccharide
(5 times)
|
Biochemistry (3 times)
|
AMMP (1 time) Ea (1 time) FAs (1 time)
|
1977 Acetylated methylmannose polysaccharide of Streptomyces.
|
32 |
middle mass peptides
(5 times)
|
Pharmacology (2 times)
|
---
|
1986 [Role of middle-molecule blood peptides in the development of cardiac depression in thermal burns].
|
33 |
modified Mallampati
(5 times)
|
Anesthesiology (4 times)
|
BMI (2 times) AASI (1 time) CL (1 time)
|
2006 Craniocervical extension improves the specificity and predictive value of the Mallampati airway evaluation.
|
34 |
multidimensional multiscale parser
(5 times)
|
Medical Informatics (3 times)
|
HEVC (1 time) PDS (1 time) SbS (1 time)
|
2008 Universal image compression using multiscale recurrent patterns with adaptive probability model.
|
35 |
Mexican Migration Project
(4 times)
|
Health Services (1 time)
|
MAFE (1 time) MEPS (1 time) PPACA (1 time)
|
2015 Mexican Immigrant Health: Health Insurance Coverage Implications.
|
36 |
mindfulness meditation practice
(4 times)
|
Psychophysiology (1 time)
|
ANS (1 time) MBCT (1 time) MMD (1 time)
|
2014 Comparison of the acceptability and benefits of two mindfulness-based interventions in women with breast or gynecologic cancer: a pilot study.
|
37 |
minimum morbidity percentile
(4 times)
|
Environmental Health (2 times)
|
OHCA (4 times) RR (1 time)
|
2016 Extreme temperature and out-of-hospital cardiac arrest in Japan: A nationwide, retrospective, observational study.
|
38 |
movement-monitoring potentials
(4 times)
|
Brain (2 times)
|
MP (2 times) MRCP (2 times) MRPs (2 times)
|
2004 Relationship between plantar-flexor torque generation and the magnitude of the movement-related potentials.
|
39 |
malignant mesothelioma of the pleura
(3 times)
|
Medicine (1 time)
|
Can-Qc (1 time)
|
1985 Trends in mortality from malignant mesothelioma of the pleura, and production and use of asbestos in Australia.
|
40 |
maximal mean power output
(3 times)
|
Sports Medicine (2 times)
|
CP (1 time)
|
2015 Impact of Altitude on Power Output during Cycling Stage Racing.
|
41 |
maximum mean pressure
(3 times)
|
Orthopedics (3 times)
|
PP (3 times) FTI (2 times) LM (1 time)
|
2005 The effect of terrain on foot pressures during walking.
|
42 |
medial midpatellar
(3 times)
|
Rheumatology (1 time)
|
AM (2 times) AL (1 time) ALJL (1 time)
|
2006 Comparison of four different intra-articular injection sites in the knee: a cadaver study.
|
43 |
medical marijuana patients
(3 times)
|
Substance-Related Disorders (3 times)
|
MM (2 times) NPU (2 times)
|
2016 Marijuana practices and patterns of use among young adult medical marijuana patients and non-patient marijuana users.
|
44 |
metal matrix proteinase
(3 times)
|
Neoplasms (1 time)
|
AQP3 (1 time) ECM (1 time) GSTP1 (1 time)
|
2013 Effect of Chinese herbs on immunoglobulin A nephropathy: a randomized controlled trial.
|
45 |
metalloproteinase to tissue inhibitors of metalloproteinase
(3 times)
|
Respiratory Tract Diseases (1 time)
|
AIA (1 time) COP (1 time) OP (1 time)
|
1998 Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing.
|
46 |
methylmercaptopurine
(3 times)
|
Pharmacology (2 times)
|
6-MP (1 time) AZA (1 time) MP (1 time)
|
2002 Pharmacological characterization of the ATP-dependent low K(m) guanosine 3',5'-cyclic monophosphate (cGMP) transporter in human erythrocytes.
|
47 |
micro manipulating probe
(3 times)
|
Diagnostic Imaging (2 times)
|
FEM (1 time)
|
2017 Controlled removal of micro/nanoscale particles in submillimeter-diameter area on a substrate.
|
48 |
Microminipig
(3 times)
|
Pharmacology (2 times)
|
CE (2 times) HDL-C (2 times) HFCD/SC (2 times)
|
2011 Microminipig, a non-rodent experimental animal optimized for life science research:novel atherosclerosis model induced by high fat and cholesterol diet.
|
49 |
modified Maquet procedure
(3 times)
|
Veterinary Medicine (3 times)
|
CCLR (1 time) PVF (1 time) TPLO (1 time)
|
2016 The Modified Maquet Procedure (MMP) in Dogs: Technical Development and Initial Clinical Experience.
|
50 |
modified multiple platform
(3 times)
|
Neurology (2 times)
|
PSD (2 times) DA (1 time) FST (1 time)
|
2004 Sleep deprivation induced by the modified multiple platform technique: quantification of sleep loss and recovery.
|
51 |
Montana Meth Project
(3 times)
|
Health Services (2 times)
|
METH (1 time) TEDS (1 time) YRBS (1 time)
|
2008 Drugs, money, and graphic ads: a critical review of the Montana Meth Project.
|
52 |
Mueller matrix polarimetry
(3 times)
|
Diagnostic Imaging (2 times)
|
OCT (1 time) PTB (1 time) SHG (1 time)
|
2017 Use of Mueller matrix polarimetry and optical coherence tomography in the characterization of cervical collagen anisotropy.
|
53 |
Multi Muscle Patterns
(3 times)
|
Physiology (3 times)
|
AFL (1 time) BMI (1 time) EMGs (1 time)
|
2008 Spherical classification of wavelet transformed EMG intensity patterns.
|
54 |
multicellular magnetotactic prokaryote
(3 times)
|
Microbiology (2 times)
|
DMO (1 time)
|
2006 Magnetic optimization in a multicellular magnetotactic organism.
|
55 |
multiple multipole
(3 times)
|
Biomedical Engineering (1 time)
|
AFM (1 time) AMS (1 time) FD (1 time)
|
1993 Multiple multipole method for simulating EM problems involving biological bodies.
|
56 |
myristoylated membrane protein
(3 times)
|
Allergy and Immunology (1 time)
|
LCDV (2 times) LCDV-PF (2 times) MCP (2 times)
|
2014 Identification of lymphocystis disease virus from paradise fish Macropodus opercularis (LCDV-PF).
|
57 |
1-methoxy-5-methylphenazinium
(2 times)
|
Chemistry Techniques, Analytical (2 times)
|
MP (1 time) PCOP (1 time)
|
1999 Uricase-catalyzed oxidation of uric acid using an artificial electron acceptor and fabrication of amperometric uric acid sensors with use of a redox ladder polymer.
|
58 |
macrophage metalloelastase
(2 times)
|
Pulmonary Medicine (1 time)
|
AAD (1 time) BAL (1 time) CAS (1 time)
|
2006 Involvement of MMP-12 and phosphodiesterase type 4 in cigarette smoke-induced inflammation in mice.
|
59 |
magnetotactic multicellular prokaryote
(2 times)
|
Biophysics (1 time)
|
---
|
2004 Observation of magnetoreceptive behavior in a multicellular magnetotactic prokaryote in higher than geomagnetic fields.
|
60 |
many-celled magnetotactic prokaryote
(2 times)
|
Diagnostic Imaging (1 time)
|
---
|
2006 Flagellar apparatus of south-seeking many-celled magnetotactic prokaryotes.
|
61 |
mean maximal power
(2 times)
|
Sports Medicine (2 times)
|
CP (1 time) GXT (1 time) PO (1 time)
|
2020 Training Characteristics and Power Profile of Professional U23 Cyclists throughout a Competitive Season.
|
62 |
medication management pathway
(2 times)
|
Drug-Related Side Effects and Adverse Reactions (1 time)
|
AF (1 time) MEs (1 time)
|
2011 A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks.
|
63 |
medium-weight molecular peptides
(2 times)
|
Therapeutics (2 times)
|
DTG (1 time) LPO (1 time)
|
1991 [The effect of combined therapy with the use of thymalin and piracetam on the level of middle-molecule peptides in the blood and on the lipid peroxidation activity in patients with diffuse toxic goiter].
|
64 |
membrane peptide
(2 times)
|
Allergy and Immunology (1 time)
|
MAP (2 times) APC (1 time) CTL (1 time)
|
2019 A peptide-based vaccine for Mycobacterium avium subspecies paratuberculosis.
|
65 |
mesenteric malperfusion
(2 times)
|
Vascular Diseases (2 times)
|
ABAD (1 time) CI (1 time) FL (1 time)
|
2019 Mesenteric Malperfusion in Acute Aortic Dissection: Challenges and Frontiers.
|
66 |
metalloproteinase matrix
(2 times)
|
Jurisprudence (1 time)
|
---
|
2003 [Immunohistochemical findings in prolonged cerebral hypoxia].
|
67 |
metastatic melanoma patients
(2 times)
|
Neoplasms (1 time)
|
BRAFi (1 time) CI (1 time) HR (1 time)
|
2015 The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600.
|
68 |
metastatic proteins metalloproteinase
(2 times)
|
Biochemistry (1 time)
|
AGS (1 time) AST (1 time) ROS (1 time)
|
2009 Theaflavins retard human breast cancer cell migration by inhibiting NF-kappaB via p53-ROS cross-talk.
|
69 |
micro-magnetic particle
(2 times)
|
Chemistry Techniques, Analytical (2 times)
|
ABC (3 times) BBC (2 times) cyto c (2 times)
|
2013 An aptamer-based bio-barcode assay with isothermal recombinase polymerase amplification for cytochrome-c detection and anti-cancer drug screening.
|
70 |
Million Mutation Project
(2 times)
|
Genetics (2 times)
|
PhenoMIP (1 time) WGS (1 time)
|
2016 Caenorhabditis elegans DAF-2 as a Model for Human Insulin Receptoropathies.
|
71 |
mitochondrial membrane-phospholipid
(2 times)
|
Digestive System Surgical Procedures (1 time)
|
CoQ10 (1 time) DCM (1 time) omega-3 PUFAs (1 time)
|
1996 Effect of protection and repair of injury of mitochondrial membrane-phospholipid on prognosis in patients with dilated cardiomyopathy.
|
72 |
mixed muscle protein
(2 times)
|
Endocrinology (1 time)
|
MHC (2 times) GC-C-IRMS (1 time) SDS-PAGE (1 time)
|
1997 Skeletal muscle myosin heavy chain synthesis in type 1 diabetes.
|
73 |
mizoribine 5'-monophosphate
(2 times)
|
Biochemistry (2 times)
|
IMPDH (2 times) TAD (1 time)
|
1995 Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding.
|
74 |
mobile measurement platform
(2 times)
|
Environmental Health (2 times)
|
BC (1 time) CO (1 time) EMFAC (1 time)
|
2011 Emission factors for high-emitting vehicles based on on-road measurements of individual vehicle exhaust with a mobile measurement platform.
|
75 |
mono-methyl mono-phosphate ester
(2 times)
|
Chemistry (2 times)
|
NBO (1 time) NEDA (1 time) QM/MM (1 time)
|
2007 Interactions between phosphate and water in solution: a natural bond orbital based analysis in a QM/MM framework.
|
76 |
Mucous membrane plasmacytosis
(2 times)
|
Otolaryngology (1 time)
|
B-CLL (1 time)
|
2008 Mucous membrane plasmacytosis of the nose in a patient affected by B-cell chronic lymphocytic leukemia.
|
77 |
mulberry marc purification
(2 times)
|
Nutritional Sciences (1 time)
|
MJP (1 time)
|
2013 Antioxidant and anti-fatigue effects of anthocyanins of mulberry juice purification (MJP) and mulberry marc purification (MMP) from different varieties mulberry fruit in China.
|
78 |
Mycophenolate mophetil
(2 times)
|
Ophthalmology (1 time)
|
HSA (1 time) MPA (1 time)
|
2012 Mycophenolate mofetil use in the treatment of noninfectious uveitis.
|
79 |
myosin/moesin phosphatase
(2 times)
|
Cell Biology (1 time)
|
Inh2 (1 time) PP1 (1 time)
|
2000 Inhibition of myosin/moesin phosphatase by expression of the phosphoinhibitor protein CPI-17 alters microfilament organization and retards cell spreading.
|
80 |
peroxynitrite-matrix metalloproteinase
(2 times)
|
Cardiology (1 time)
|
CAD (1 time) iNOS (1 time) LVEF (1 time)
|
2010 Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats.
|
81 |
2-methoxy-2-methyl propanal
(1 time)
|
Biology (1 time)
|
MMP-acid (1 time) MMP-OH (1 time) MTBE (1 time)
|
2009 Advanced oxidation and reduction process chemistry of methyl tert-butyl ether (MTBE) reaction intermediates in aqueous solution: 2-methoxy-2-methyl-propanal, 2-methoxy-2-methyl-propanol, and 2-methoxy-2-methyl-propanoic acid.
|
82 |
2-methoxy-2-methyl propionaldehyde
(1 time)
|
Environmental Health (1 time)
|
AC (1 time) AOP (1 time) FA (1 time)
|
2001 MTBE oxidation by conventional ozonation and the combination ozone/hydrogen peroxide: efficiency of the processes and bromate formation.
|
83 |
2-methoxy-6-methylpyridine
(1 time)
|
Medicine (1 time)
|
MTBE (1 time)
|
2019 Efficacy and safety of a novel topical agent for gallstone dissolution: 2-methoxy-6-methylpyridine.
|
84 |
3-mercaptomethylpropionate
(1 time)
|
Chemistry (1 time)
|
MNIC (1 time)
|
2014 Transformation of a mononitrosyl iron complex to a [2Fe-2S] cluster by a cysteine analogue.
|
85 |
3-methyl-4-(methylthio)phenol
(1 time)
|
Environmental Health (1 time)
|
hERalpha (1 time) HPLC (1 time) MMS (1 time)
|
2009 A novel estrogenic compound transformed from fenthion under UV-A irradiation.
|
86 |
3-O-methyl-D-mannose-containing polysaccharide
(1 time)
|
Biochemistry (1 time)
|
SD-MMP (1 time)
|
1977 Heterogeneity and refined structtures of 3-O-methyl-D-mannose polysaccharides from Mycobacterium smegmatis.
|
87 |
actin-collagen-matrix metalloproteinases
(1 time)
|
Medicine (1 time)
|
NHP (1 time)
|
2011 Improved xenobiotic metabolism and reduced susceptibility to cancer in gluten-sensitive macaques upon introduction of a gluten-free diet.
|
88 |
c-Myc, p53, Bax, Bcl-2, metalloproteinase
(1 time)
|
Medicine (1 time)
|
MDM2 (1 time) VEGF (1 time)
|
2016 [Effect and Regulatory Mechanism of Clock Gene Per1 on Biological Behaviors of Human Oral Squamous Carcinoma Cell].
|
89 |
Epac1-to-matrix metalloprotease
(1 time)
|
Neurology (1 time)
|
Epac1 (1 time)
|
2013 Role of HIF-1alpha-activated Epac1 on HSC-mediated neuroplasticity in stroke model.
|
90 |
Fe3O4-magainins I nanocomposites
(1 time)
|
Chemistry (1 time)
|
PIP (1 time)
|
2020 Sandwich immunoassay based on antimicrobial peptide-mediated nanocomposite pair for determination of Escherichia coli O157:H7 using personal glucose meter as readout.
|
91 |
lysoPC-mediated proliferation could occur by stimulating metalloproteinase
(1 time)
|
Pharmacology (1 time)
|
lysoPC (1 time) oxLDL (1 time) SMC (1 time)
|
2002 Smooth muscle cell proliferation induced by oxidized LDL-borne lysophosphatidylcholine. Evidence for FGF-2 release from cells not extracellular matrix.
|
92 |
Macrophage membrane potential
(1 time)
|
Biology (1 time)
|
---
|
1975 [Macrophage membrane potential test: an electrophysiological modification of the Field-Caspary test in melanoma patients].
|
93 |
macrophage membrane proteins
(1 time)
|
Medicine (1 time)
|
CA (1 time) Hc (1 time)
|
2003 Interaction of Histoplasma capsulatum yeasts with galactosylated surface molecules of murine macrophages.
|
94 |
magnetic mesoporous phenolic resin
(1 time)
|
Chemistry Techniques, Analytical (1 time)
|
PEI (1 time)
|
2018 In Situ Synthesis of Magnetic Mesoporous Phenolic Resin for the Selective Enrichment of Glycopeptides.
|
95 |
magnetic mesoporous polydopamine microspheres
(1 time)
|
Biomedical Research (1 time)
|
denoted as abc-DIAP (1 time) MMC (1 time)
|
2020 Interface Coassembly and Polymerization on Magnetic Colloids: Toward Core-Shell Functional Mesoporous Polymer Microspheres and Their Carbon Derivatives.
|
96 |
magnetic microparticles probe
(1 time)
|
Virology (1 time)
|
CV (1 time) GNPA (1 time) HCV (1 time)
|
2017 An improved gold nanoparticle probe-based assay for HCV core antigen ultrasensitive detection.
|
97 |
magnetic mineral particles
(1 time)
|
Microbiology (1 time)
|
RML (1 time) XRD (1 time)
|
2009 Effect of oxidative stress on the growth of magnetic particles in Magnetospirillum magneticum.
|
98 |
mainly by inhibition of metalloproteinase
(1 time)
|
Medicine (1 time)
|
Hh (1 time)
|
2013 Irradiated riboflavin diminishes the aggressiveness of melanoma in vitro and in vivo.
|
99 |
maintenance methadone programmes
(1 time)
|
Pulmonary Medicine (1 time)
|
CI (1 time) DOT (1 time) HIV (1 time)
|
1998 Predictors of adherence to tuberculosis treatment in a supervised therapy programme for prisoners before and after release. Study Group of Adherence to Tuberculosis Treatment of Prisoners.
|
100 |
Mais Medicos programme
(1 time)
|
Medicine (1 time)
|
ACSCs (1 time) ESF (1 time) SDGs (1 time)
|
2019 Mortality associated with alternative primary healthcare policies: a nationwide microsimulation modelling study in Brazil.
|